AI in IVF 2026: Composite Receptivity Scoring, Personalised Dose-Response Curves, and Metabolomic SCM Profiling
Clinical Disclaimer: For clinician education only; not patient-specific medical advice.
Welcome to the March 10, 2026, edition of Fertility Insights. As the reproductive landscape shifts toward high-precision digital health, Santaan remains committed to translating the latest AI breakthroughs into superior clinical outcomes. Today, we move beyond standalone embryo grading to examine Multi-Dimensional Composite Scoring, the clinical launch of Personalised Dose-Response AI for stimulation, and the latest meta-analysis on Spent Culture Media (SCM) metabolic biomarkers.
🔬 Clinical Deep Dive: The CS = (EQS + ERS)/2 Framework
The most significant shift in early 2026 is the transition from isolated embryo selection to Composite Scoring (CS). A landmark study published in Frontiers in Artificial Intelligence (March 2026) validates a framework that integrates embryo quality with automated endometrial receptivity.
• Mechanism: The system uses a U-Net CNN with a VGG16 backbone for automated endometrial segmentation, extracting thickness and trilaminar patterns. This is mathematically combined with an AI-derived Embryo Quality Score (EQS) and SART clinical probability data.
• Evidence Level: High (Internal validation shows an AUC of 0.94 for biochemical pregnancy, significantly outperforming standalone embryo or uterine markers).
• Clinical Value: At an optimal cutoff of CS ≥ 6.5, the model reached a 92.1% sensitivity and 91.0% positive predictive value (PPV), offering a robust tool for “Freeze-All” decision support when the uterine environment is suboptimal.
• Citation: “Artificial intelligence models and combined scoring approaches for endometrial receptivity assessment,” Frontiers in AI (March 2026) / DOI: 10.3389/frai.2025.1673800.
🤖 InOvaSGuide: Personalised Dose-Response AI
Standardising the starting dose of FSH is being revolutionised by the InOvaSGuide prototype, an integrated framework for predicting Ovarian Response (NOR) and OHSS risk simultaneously.
• The Innovation: Rather than a static dose based on weight or AMH, the AI generates Individualised Dose-Response Curves. These curves display the predicted number of oocytes and the probability of moderate-to-severe OHSS across a range of FSH doses.
• Performance: Recent multicenter evaluations show that AI-assisted dosing matched or exceeded REI performance in 76% of cases, particularly in preventing over-prediction of mature oocytes in high-responders.
• Internal Resource: Explore our Precision Ovarian Stimulation Protocols.
• Citation: “Integrated Prediction System for Individualised Ovarian Stimulation and OHSS Prevention,” JMIR (2026) / PMID: [41229699].
🧬 Metabolic Profiling of SCM: The ‘Secretome’ Update
While image-based AI dominates, Spent Culture Media (SCM) analysis is maturing. A 2026 meta-analysis has identified specific low-molecular-weight metabolites that serve as objective biomarkers for embryo viability.
• Key Findings: Seven metabolites were positively associated with implantation, while ten were identified as negative markers. This “metabolic signature” allows for a label-free, non-invasive assessment of the embryo’s developmental competence.
• Evidence Level: Moderate (Technological validation complete; larger prospective trials required for universal clinical adoption).
• Internal Resource: Discover Santaan’s Advanced Embryology Lab Technology.
• Citation: “The quest for metabolic biomarkers of IVF outcomes: a meta-analysis,” Frontiers in Cell and Dev. Bio. (2025/2026) / DOI: 10.3389/fcell.2025.1640807.
📈 Santaan’s Scientific Leadership
At Santaan, we emphasise Explainable AI (XAI). We believe that transparency, showing the clinician the “attribution maps” behind an AI score, is essential for trust. For a deeper technical dive into our U-Net architectures and SCM profiling, visit: Santaan IVF on Medium.
Connect With Us
For Clinicians: Stay at the forefront of reproductive science. Join our digital health collaborative to access real-time AI-driven benchmarks and advanced dose-prediction tools.
👉 Contact our Clinical Relations Team
https://www.google.com/search?q=https://santaan.in/contact-us
Technical Metadata